• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH PLUS INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH PLUS INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Model Number 914ESPA
Medical Device Problem Codes Detachment of Device or Device Component (2907); Material Split, Cut or Torn (4008)
Health Effect - Clinical Code Foreign Body Embolism (4439)
Date of Event 02/11/2026
Type of Reportable Event Serious Injury
Event or Problem Description
As reported by the field clinical specialist (fcs), during implant of a 23 mm sapien 3 ultra resilia valve in the aortic position via left transfemoral approach, during inflation of the commander delivery system while deploying the valve, there was asymmetrical inflation and delay of inflation occurred at the distal portion of the balloon.The valve was successfully deployed with no patient injuries due to the inflation problems.The patient was stable and awaiting vascular repair for a non-edwards closure device injury.Per imaging review, esheath+ distal tip tear and system components separate were found.
 
Additional Manufacturer Narrative
This is two of two manufacturer reports being submitted for this case.The investigation is ongoing.
 
Additional Manufacturer Narrative
H6 investigation findings: separation problem: the event reported is an anticipated in the risk management documentation for transcatheter heart valve procedures.A previous investigation into this type of event is captured in an edwards lifesciences technical summary and applies to this complaint.Additional assessment of the failure mode is not required at this time.The device was not returned for evaluation.Due to the unavailability of the complaint device, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.Per the technical summary, the ifu, current risk mitigations include design and manufacturing controls, and training manuals have been reviewed, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Provided procedural fluoroscopic imagery as well as the 3mensio, revealing calcification in the patient's left access vessel/abdominal aorta.In this case, the complaints for sheath distal tip torn and system components separate during use were confirmed based on evaluation of the provided procedural fluoroscopic imagery.The capa investigation has determined that esheath/esheath+ tip expansion performance may be influenced by patient specific anatomical factors, procedural factors, and manufacturing related variables.As part of this investigation, manufacturing evaluations identified opportunities for improvement that may further support consistent tip expansion, including under challenging anatomical and procedural conditions.These manufacturing improvement opportunities include defining axial outer diameter score depth requirements and adding procedural controls to reduce inner diameter surface damage, thereby supporting more robust and consistent tip expansion.Patient and/or procedural factors ' such as challenging anatomy or non-coaxial advancement ' may further exacerbate interference between the valve and distal tip, leading to increased resistance and potential tearing during system advancement.High push forces applied to overcome resistance during system advancement can further contribute to tip tearing and subject it towards separation.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.An investigation has been opened to determine the root cause and implement any necessary corrective actions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH PLUS INTRODUCER SHEATH
Common Device Name
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key24746546
Report Number2015691-2026-13719
Device Sequence Number8780497
Product Code DYB
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
K200258
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/20/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number914ESPA
Device Lot Number67066660
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/23/2026
Supplement Date Received by Manufacturer05/19/2026
Initial Report FDA Received Date03/31/2026
Supplement Report FDA Received Date05/20/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/15/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
Patient SexFemale
-
-